Physician profile
Dina Obed
NPI 1871053652
$5,084.62
in general payments reported to CMS, 2019-2025
5 companies · $4,272 in 2025
The $4,272 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $813 · 2025: $4,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,983 · Food and Beverage: $740 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,983.00 |
| Food and Beverage | $740.40 |
| Education | $361.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,549.75 | 2024-2025 | Silverhawk, Endurant Iis, Hawkone |
| Silk Road Medical, INC. | $297.32 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $171.17 | 2024-2025 | Accolade Sr, Eluvia |
| Inari Medical, INC. | $47.77 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Imperative Care, INC | $18.61 | 2024 | Prodigy Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Obed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.